Cian McCarthy, Mb.Bch,Bao
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Infarction | 34 | 2024 | 11890 | 4.410 |
Why?
|
Troponin | 9 | 2023 | 516 | 3.050 |
Why?
|
Troponin I | 7 | 2024 | 638 | 2.290 |
Why?
|
Chest Pain | 7 | 2022 | 1106 | 1.650 |
Why?
|
Morphine | 4 | 2017 | 655 | 1.650 |
Why?
|
Anterior Wall Myocardial Infarction | 2 | 2023 | 43 | 1.610 |
Why?
|
Acute Coronary Syndrome | 9 | 2024 | 2365 | 1.610 |
Why?
|
Patient Readmission | 10 | 2021 | 3322 | 1.500 |
Why?
|
Coronary Stenosis | 4 | 2023 | 820 | 1.180 |
Why?
|
International Classification of Diseases | 5 | 2021 | 894 | 0.970 |
Why?
|
Coronary Angiography | 10 | 2023 | 4563 | 0.960 |
Why?
|
Cardiovascular Diseases | 18 | 2024 | 15760 | 0.960 |
Why?
|
Diagnostic Errors | 2 | 2024 | 1266 | 0.940 |
Why?
|
Coronary Artery Disease | 9 | 2023 | 6659 | 0.880 |
Why?
|
Bullying | 2 | 2016 | 221 | 0.850 |
Why?
|
Vasodilator Agents | 2 | 2017 | 978 | 0.800 |
Why?
|
Medical Staff, Hospital | 2 | 2016 | 600 | 0.780 |
Why?
|
Thrombosis | 4 | 2022 | 3051 | 0.780 |
Why?
|
Teaching Rounds | 2 | 2016 | 275 | 0.770 |
Why?
|
Anticoagulants | 6 | 2022 | 4897 | 0.760 |
Why?
|
Plaque, Atherosclerotic | 2 | 2023 | 1518 | 0.700 |
Why?
|
Platelet Aggregation Inhibitors | 6 | 2022 | 3200 | 0.690 |
Why?
|
Economics, Hospital | 2 | 2019 | 212 | 0.690 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2023 | 329 | 0.660 |
Why?
|
Troponin T | 3 | 2023 | 774 | 0.600 |
Why?
|
Fibrinolytic Agents | 2 | 2018 | 2167 | 0.590 |
Why?
|
Antihypertensive Agents | 2 | 2024 | 2061 | 0.590 |
Why?
|
Proteomics | 3 | 2020 | 3817 | 0.570 |
Why?
|
Heart Injuries | 1 | 2019 | 208 | 0.570 |
Why?
|
Health Services Misuse | 1 | 2019 | 245 | 0.560 |
Why?
|
Caricatures as Topic | 1 | 2016 | 1 | 0.550 |
Why?
|
Medicare | 6 | 2024 | 6785 | 0.550 |
Why?
|
Hypertension | 4 | 2024 | 8595 | 0.540 |
Why?
|
Physicians | 3 | 2020 | 4591 | 0.540 |
Why?
|
Natriuretic Peptides | 1 | 2017 | 156 | 0.540 |
Why?
|
Conflict of Interest | 2 | 2018 | 549 | 0.540 |
Why?
|
Trimetazidine | 1 | 2015 | 2 | 0.540 |
Why?
|
Metaphor | 1 | 2016 | 41 | 0.530 |
Why?
|
Patient Care Management | 1 | 2019 | 303 | 0.520 |
Why?
|
Cardiology | 4 | 2022 | 1723 | 0.520 |
Why?
|
Nitrates | 1 | 2017 | 264 | 0.520 |
Why?
|
Program Development | 2 | 2018 | 1297 | 0.500 |
Why?
|
Humans | 93 | 2024 | 760613 | 0.500 |
Why?
|
Heart Failure | 7 | 2022 | 11848 | 0.500 |
Why?
|
Models, Organizational | 1 | 2018 | 545 | 0.490 |
Why?
|
Specialization | 1 | 2020 | 778 | 0.490 |
Why?
|
Health Status Indicators | 1 | 2020 | 968 | 0.480 |
Why?
|
Catheterization, Peripheral | 1 | 2018 | 342 | 0.480 |
Why?
|
Peroxidase | 1 | 2017 | 605 | 0.470 |
Why?
|
Prognosis | 17 | 2024 | 29661 | 0.470 |
Why?
|
Education, Medical | 2 | 2016 | 1727 | 0.460 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2017 | 404 | 0.450 |
Why?
|
Reimbursement, Incentive | 1 | 2019 | 542 | 0.450 |
Why?
|
Aortic Valve Stenosis | 2 | 2017 | 2065 | 0.450 |
Why?
|
Predictive Value of Tests | 10 | 2023 | 15286 | 0.440 |
Why?
|
Metabolic Diseases | 1 | 2020 | 685 | 0.430 |
Why?
|
Warfarin | 2 | 2022 | 1518 | 0.430 |
Why?
|
Blood Proteins | 1 | 2018 | 1173 | 0.420 |
Why?
|
Students, Medical | 2 | 2016 | 1927 | 0.410 |
Why?
|
Heparin | 1 | 2020 | 1652 | 0.410 |
Why?
|
Risk Assessment | 12 | 2020 | 24102 | 0.410 |
Why?
|
Coronary Vessel Anomalies | 1 | 2015 | 317 | 0.390 |
Why?
|
Watchful Waiting | 1 | 2016 | 510 | 0.390 |
Why?
|
Angina Pectoris | 1 | 2015 | 969 | 0.390 |
Why?
|
Sex Factors | 6 | 2021 | 10546 | 0.380 |
Why?
|
C-Reactive Protein | 4 | 2022 | 3839 | 0.380 |
Why?
|
Hospitalization | 4 | 2022 | 10789 | 0.380 |
Why?
|
Heart Diseases | 3 | 2021 | 2809 | 0.380 |
Why?
|
Patient Discharge | 3 | 2020 | 3474 | 0.360 |
Why?
|
Disease Management | 2 | 2018 | 2514 | 0.350 |
Why?
|
Thrombocytopenia | 1 | 2017 | 1174 | 0.340 |
Why?
|
Practice Guidelines as Topic | 7 | 2024 | 7475 | 0.340 |
Why?
|
Information Dissemination | 1 | 2018 | 1131 | 0.340 |
Why?
|
Medicaid | 3 | 2019 | 2815 | 0.340 |
Why?
|
Health Care Reform | 1 | 2018 | 1245 | 0.330 |
Why?
|
Thrombolytic Therapy | 1 | 2018 | 2108 | 0.320 |
Why?
|
Coronary Vessels | 2 | 2021 | 3112 | 0.320 |
Why?
|
Analgesics, Opioid | 4 | 2017 | 3763 | 0.320 |
Why?
|
Heart Valve Prosthesis | 1 | 2017 | 1495 | 0.310 |
Why?
|
Salaries and Fringe Benefits | 2 | 2021 | 258 | 0.310 |
Why?
|
Arrhythmias, Cardiac | 2 | 2024 | 2255 | 0.310 |
Why?
|
United States | 19 | 2024 | 72448 | 0.300 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2019 | 2128 | 0.300 |
Why?
|
Faculty, Medical | 1 | 2016 | 1192 | 0.290 |
Why?
|
Peripheral Arterial Disease | 2 | 2018 | 1305 | 0.290 |
Why?
|
Mitral Valve Insufficiency | 1 | 2017 | 1419 | 0.280 |
Why?
|
Quality of Health Care | 2 | 2018 | 4360 | 0.270 |
Why?
|
Health Policy | 1 | 2018 | 2677 | 0.260 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2016 | 1582 | 0.250 |
Why?
|
Aged | 20 | 2024 | 169143 | 0.240 |
Why?
|
Dyslipidemias | 2 | 2022 | 895 | 0.230 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3527 | 0.230 |
Why?
|
Acute Kidney Injury | 3 | 2022 | 1941 | 0.230 |
Why?
|
Patient Selection | 1 | 2016 | 4279 | 0.220 |
Why?
|
Male | 30 | 2024 | 359718 | 0.220 |
Why?
|
Echocardiography | 1 | 2016 | 4981 | 0.220 |
Why?
|
Coronary Disease | 2 | 2017 | 5991 | 0.220 |
Why?
|
Middle Aged | 21 | 2023 | 220359 | 0.220 |
Why?
|
Aspirin | 3 | 2020 | 3364 | 0.210 |
Why?
|
Prospective Studies | 10 | 2023 | 54306 | 0.210 |
Why?
|
Survival Analysis | 4 | 2019 | 10185 | 0.210 |
Why?
|
Risk Factors | 14 | 2023 | 74333 | 0.200 |
Why?
|
Hospital Mortality | 4 | 2021 | 5418 | 0.200 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3332 | 0.200 |
Why?
|
Female | 29 | 2024 | 391246 | 0.200 |
Why?
|
Incidence | 6 | 2019 | 21391 | 0.190 |
Why?
|
Massachusetts | 3 | 2019 | 8803 | 0.190 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2020 | 1716 | 0.190 |
Why?
|
Fellowships and Scholarships | 2 | 2020 | 1116 | 0.190 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2024 | 504 | 0.180 |
Why?
|
Severity of Illness Index | 5 | 2019 | 15840 | 0.180 |
Why?
|
Emergency Service, Hospital | 3 | 2022 | 7818 | 0.180 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1098 | 0.170 |
Why?
|
Hyperlipoproteinemias | 1 | 2019 | 20 | 0.170 |
Why?
|
Cause of Death | 2 | 2020 | 3725 | 0.160 |
Why?
|
Catheter Ablation | 2 | 2024 | 2758 | 0.150 |
Why?
|
Sus scrofa | 1 | 2020 | 433 | 0.150 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2019 | 152 | 0.150 |
Why?
|
Peripheral Vascular Diseases | 1 | 2021 | 515 | 0.150 |
Why?
|
Insurance, Health | 2 | 2021 | 2501 | 0.150 |
Why?
|
Comorbidity | 3 | 2024 | 10553 | 0.150 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2019 | 364 | 0.140 |
Why?
|
Mendelian Randomization Analysis | 1 | 2023 | 998 | 0.140 |
Why?
|
Drug Therapy, Combination | 2 | 2017 | 6498 | 0.140 |
Why?
|
Length of Stay | 3 | 2021 | 6476 | 0.140 |
Why?
|
Endothelin-1 | 1 | 2018 | 302 | 0.140 |
Why?
|
Apolipoproteins | 1 | 2019 | 320 | 0.140 |
Why?
|
Angiography | 2 | 2022 | 1605 | 0.140 |
Why?
|
Receptors, Interleukin-1 | 1 | 2018 | 261 | 0.140 |
Why?
|
Prevalence | 5 | 2022 | 15686 | 0.140 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 2290 | 0.130 |
Why?
|
Ischemic Preconditioning, Myocardial | 1 | 2016 | 69 | 0.130 |
Why?
|
Coronary Care Units | 1 | 2018 | 235 | 0.130 |
Why?
|
Drug Labeling | 1 | 2018 | 251 | 0.130 |
Why?
|
Neprilysin | 1 | 2019 | 472 | 0.130 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 664 | 0.130 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 1166 | 0.130 |
Why?
|
Hospitals | 2 | 2020 | 3928 | 0.130 |
Why?
|
Referral and Consultation | 2 | 2019 | 3598 | 0.130 |
Why?
|
Catheters | 1 | 2018 | 425 | 0.130 |
Why?
|
Boston | 2 | 2019 | 9278 | 0.130 |
Why?
|
ROC Curve | 2 | 2020 | 3568 | 0.130 |
Why?
|
Aged, 80 and over | 7 | 2024 | 58980 | 0.120 |
Why?
|
Echocardiography, Doppler | 1 | 2019 | 901 | 0.120 |
Why?
|
Retrospective Studies | 7 | 2021 | 80345 | 0.120 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7805 | 0.120 |
Why?
|
Cardiovascular System | 1 | 2022 | 850 | 0.120 |
Why?
|
Hospital Costs | 1 | 2021 | 976 | 0.120 |
Why?
|
Angina, Unstable | 1 | 2019 | 926 | 0.120 |
Why?
|
Primary Prevention | 2 | 2019 | 1207 | 0.120 |
Why?
|
Models, Economic | 1 | 2018 | 719 | 0.120 |
Why?
|
Adiponectin | 1 | 2020 | 1114 | 0.120 |
Why?
|
Myocardial Revascularization | 1 | 2018 | 841 | 0.120 |
Why?
|
Physicians, Women | 1 | 2019 | 495 | 0.110 |
Why?
|
China | 1 | 2020 | 2339 | 0.110 |
Why?
|
Electrocardiography | 2 | 2019 | 6415 | 0.110 |
Why?
|
United States Food and Drug Administration | 2 | 2019 | 1677 | 0.110 |
Why?
|
Drug Industry | 1 | 2020 | 789 | 0.110 |
Why?
|
Tetrazoles | 1 | 2019 | 905 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5890 | 0.110 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2016 | 479 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 12289 | 0.100 |
Why?
|
Time Factors | 3 | 2020 | 40139 | 0.100 |
Why?
|
Disclosure | 1 | 2018 | 738 | 0.100 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12968 | 0.100 |
Why?
|
Treatment Outcome | 6 | 2019 | 64981 | 0.100 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2019 | 1046 | 0.100 |
Why?
|
Coronary Occlusion | 1 | 2015 | 309 | 0.100 |
Why?
|
Telemedicine | 2 | 2019 | 3018 | 0.100 |
Why?
|
Myocardial Ischemia | 1 | 2022 | 2164 | 0.100 |
Why?
|
Coronary Artery Bypass | 1 | 2021 | 2272 | 0.100 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39262 | 0.090 |
Why?
|
Mortality | 2 | 2019 | 2916 | 0.090 |
Why?
|
Blood Pressure | 2 | 2024 | 8525 | 0.090 |
Why?
|
Cholesterol, HDL | 1 | 2017 | 1817 | 0.090 |
Why?
|
Outpatients | 1 | 2018 | 1607 | 0.090 |
Why?
|
Program Evaluation | 1 | 2019 | 2493 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1796 | 0.090 |
Why?
|
Stroke Volume | 2 | 2021 | 5523 | 0.090 |
Why?
|
Thrombectomy | 1 | 2015 | 708 | 0.090 |
Why?
|
Income | 1 | 2018 | 1875 | 0.080 |
Why?
|
Contrast Media | 2 | 2022 | 5305 | 0.080 |
Why?
|
Bariatric Surgery | 1 | 2019 | 1005 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20080 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1673 | 0.080 |
Why?
|
Radiation Injuries | 1 | 2016 | 1183 | 0.080 |
Why?
|
Hypoglycemic Agents | 2 | 2019 | 3149 | 0.080 |
Why?
|
Odds Ratio | 2 | 2018 | 9716 | 0.080 |
Why?
|
Databases, Factual | 2 | 2021 | 8022 | 0.080 |
Why?
|
Death, Sudden, Cardiac | 1 | 2017 | 1572 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 3880 | 0.080 |
Why?
|
Obesity, Morbid | 1 | 2019 | 1287 | 0.080 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2884 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7268 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1822 | 0.080 |
Why?
|
Cohort Studies | 3 | 2019 | 41337 | 0.070 |
Why?
|
Cholesterol, LDL | 1 | 2017 | 2420 | 0.070 |
Why?
|
Survival Rate | 2 | 2019 | 12810 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 25941 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4434 | 0.070 |
Why?
|
Delirium | 1 | 2018 | 1663 | 0.070 |
Why?
|
Health Expenditures | 1 | 2018 | 2362 | 0.070 |
Why?
|
Aortic Valve | 1 | 2016 | 1996 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2363 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14661 | 0.060 |
Why?
|
Disease Progression | 2 | 2018 | 13505 | 0.060 |
Why?
|
Artificial Intelligence | 1 | 2019 | 2557 | 0.060 |
Why?
|
Cardiac Electrophysiology | 1 | 2024 | 59 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9468 | 0.060 |
Why?
|
Smoking | 1 | 2021 | 9073 | 0.060 |
Why?
|
Inflammation | 2 | 2022 | 10755 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12628 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20509 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 15790 | 0.050 |
Why?
|
Registries | 1 | 2019 | 8458 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 151 | 0.050 |
Why?
|
Obesity | 2 | 2022 | 12919 | 0.050 |
Why?
|
Censuses | 1 | 2022 | 201 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 22052 | 0.050 |
Why?
|
New England | 1 | 2024 | 1050 | 0.050 |
Why?
|
Cystatin C | 1 | 2022 | 270 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2019 | 5209 | 0.050 |
Why?
|
Interleukin-18 | 1 | 2022 | 251 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10343 | 0.040 |
Why?
|
Osteopontin | 1 | 2022 | 302 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2015 | 4446 | 0.040 |
Why?
|
Vitamin K | 1 | 2022 | 321 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9952 | 0.040 |
Why?
|
Pharmacological Phenomena | 1 | 2019 | 11 | 0.040 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 8055 | 0.040 |
Why?
|
Animals | 3 | 2020 | 167960 | 0.040 |
Why?
|
American Heart Association | 1 | 2022 | 1081 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3441 | 0.040 |
Why?
|
Hemorrhage | 2 | 2019 | 3599 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2022 | 1725 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2019 | 667 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2294 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12531 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2019 | 992 | 0.030 |
Why?
|
Diabetic Angiopathies | 1 | 2019 | 822 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2020 | 1548 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2932 | 0.030 |
Why?
|
Creatinine | 1 | 2019 | 1904 | 0.030 |
Why?
|
Catheterization | 1 | 2018 | 1432 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2025 | 0.030 |
Why?
|
Drug Utilization | 1 | 2019 | 1195 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 965 | 0.030 |
Why?
|
Radiography | 1 | 2024 | 6965 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2924 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3113 | 0.030 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 866 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1031 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3215 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1657 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2192 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4035 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2019 | 6238 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2022 | 3812 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2180 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2021 | 2093 | 0.020 |
Why?
|
Heart Valve Diseases | 1 | 2016 | 1047 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2019 | 1939 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8483 | 0.020 |
Why?
|
Health Promotion | 1 | 2019 | 2207 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10826 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9288 | 0.020 |
Why?
|
Algorithms | 1 | 2024 | 13982 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12914 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5325 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36286 | 0.010 |
Why?
|
Adult | 1 | 2019 | 220007 | 0.000 |
Why?
|